Crossmark

Infliximab en enfermedad inflamatoria intestinal. ¿Es necesario premedicar?

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2020.07.018

Published Print: 2021-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nuñez F., Paulina

Quera, Rodrigo

Simian, Daniela

Flores, Lilian

Figueroa, Carolina

Ibañez, Patricio

Kronberg, Udo

Lubascher, Jaime

Pizarro, Gonzalo
License Information

Text and Data Mining valid from 2021-05-01
More Information

This article is maintained by: Elsevier

Article Title: Infliximab en enfermedad inflamatoria intestinal. ¿Es necesario premedicar?

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2020.07.018

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.